Erik Baas

  • Former director business development, Medtronic, Geneva, Switzerland

    Erik Baas was the former Director, Medicine and Technology, International at Medtronic where he was responsible for scouting for emerging technologies that will have an impact on Medtronic. In close partnership with Medtronic corporate and business units, he developed close collaborations with VC firms, technical universities in Europe and Israel and Medtronic’s diverse customer base. Erik Baas has worked within the biomedical, pharmaceutical, bioscience and IT fields where he has held roles in project management, business planning, and market development . His previous appointments have included the Netherlands Cancer Institute, Genencor International, Arthur D. Little, Geneva Bioinformatics, and Glaucus Proteomics. In 2002, Erik founded Arrante Bioscience in Holland, a company specialized in the development of protein biochips and production of various applications. Erik holds an MS in Biochemistry and Molecular Biology from the University of Amsterdam, a PhD in Biochemistry from the Free University of Amsterdam and an MBA from IMD in Lausanne.

  • Conference Info:


    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City

    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!